Consolidated Statement of Cash Flows (Unaudited) (USD $)	3 Months Ended		173 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (3,429,708)	$ (15,906,647)	$ (33,207,618)
Adjustments to reconcile net loss to net cash used in operating activities
Fair value of options issued in exchange for services	740,954	332,598	11,777,323
Accretion of interest on deferred finance charges			453,625
Accretion of discount on notes payable		1,239	446,954
Change in fair value warrant liability	890,000	11,921,510	1,494,209
Change in fair value embedded derivative liability	300,000		100,000
Fair value of warrants in excess of consideration for convertible preferred stock		2,995,791	2,995,791
Fair value of stock in excess of converted notes payable and accrued interest			1,221,875
Salary due to stockholder contributed to capital			15,000
Amortization and depreciation	20,590	6,045	632,574
Gain on disposition of assets			(4,722)
Gain on debt forgiveness			(340,352)
Stock & warrants issued in exchange for technology	844,000		1,397,760
Financing expenses paid directly from stock proceeds			5,270
Amortization of deferred consulting fees			40,800
(Increase) decrease in assets
Accounts receivable		(3,140)	(3,573)
Inventory		(9,872)	5,689
Prepaid expenses	2,632	137,133	213,158
Deposit			(37,197)
Increase in liabilities
Accounts payable and accrued expenses	(75,100)	(220,820)	2,258,765
Net cash used in operating activities	(706,632)	(746,163)	(10,534,669)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment		(7,329)	(48,682)
Purchase of patents and trademarks		(18,443)	(246,088)
Proceeds from sale of assets			6,738
Net cash used in investing activities		(25,772)	(288,032)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of preferred stock		1,000,000	1,000,000
Proceeds from issuance of common stock		235,000	5,786,447
Proceeds from exercise of stock options		17,919	273,401
Proceeds issuance of stock options			15,000
Proceeds from exercise of warrants		10,000	115,500
Proceeds from issuance of warrants			2,000,000
Proceeds from issuance of notes payable			2,789,000
Repayments of notes payable			(352,751)
Payment for treasury stock			(17,795)
Debt issuance costs			(62,000)
Stock issuance costs			(144,760)
Net cash provided by financing activities		1,262,919	11,402,042
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(706,632)	490,984	579,341
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	1,285,973	2,994,350
CASH AND CASH EQUIVALENTS - END OF PERIOD	579,341	3,485,334	579,341
Cash paid during the year for:
Interest		13,896	53,336
Income taxes
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Cashless exercise of options	2,714		2,714
Return of shares of common stock related to purchase price adjustment
Common stock			(1,000)
Additional paid-in capital			(353,000)
Intangible assets			(354,000)
Issuance of common stock and stock options for acquisition of subsidiary			738,000
Proceeds from common stock sales applied directly to debt and financing expenses repayment			55,270
Fair value of warrants issued for deferred finance charges			392,376
Fair value of stock issued for conversion of notes payable and accrued interest		262,000	2,985,680
Fair value of stock issued for conversion of preferred stock to common stock			366,667
Fair value of stock issued for purchase of assets			100,000
Fair value of warrants issued for purchase of assets			100,000
Fair value of stock issued for licensing costs			100,000
Fair value of warrants issued for licensing costs			300,000
Accretion of discount on preferred stock as deemed dividend distribution		1,000,000	1,000,000
Fair value of beneficial conversion feature		1,000,000	1,500,000
Fair value of warrants issued as debt discount	0		78,043
Issuance of common stock for stock issuance costs	0		2,100
Issuance of options as stock cost for treasury stock	0		5,594
Forgiveness of debt-related party treated as additional paid in capital			349,000
Conversion of warrant in lieu of cash repayment of notes payable			$ 60,000